{"database": "lobbying", "table": "lobbying_activities", "rows": [[2192101, "ad1d3889-0f06-4e5e-862c-0f80a63b9299", "Q3", "CAPITOL HILL STRATEGIES,  LLC", 91774, "BIOGEN INC", 2018, "third_quarter", "MED", "Issues dealing with newborn screening.\nIssues dealing with Alzheimer's treatments.\nIssues dealing with the addition of Spinal Muscular Atrophy to the Recommended Uniform Screening Panel.", "HOUSE OF REPRESENTATIVES,SENATE", 40000, null, 0, 0, "2018-10-18T15:04:53.357000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2192101"], "units": {}, "query_ms": 4.864724003709853, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}